Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,662 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current State of Fibrotic Interstitial Lung Disease Imaging.
Chelala L, Brixey AG, Hobbs SB, Kanne JP, Kligerman SJ, Lynch DA, Chung JH. Chelala L, et al. Among authors: chung jh. Radiology. 2025 Jul;316(1):e242531. doi: 10.1148/radiol.242531. Radiology. 2025. PMID: 40590695 Review.
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors.
Ku G, Shen L, Dayyani F, Kratz J, Liang X, Liu F, Wang Z, Feller L, Girda E, Pan H, Kim S, Deng Y, Deng T, Liu T, Powderly J, Spencer K, Schneider R, Berlin J, Xu CC, Ahlers CM, Liu X, Chung JK, Sabbatini P, Park J, Lim Y, Jeon J, Meng Y, Klempner SJ. Ku G, et al. Among authors: chung jk. Clin Cancer Res. 2025 Jun 30. doi: 10.1158/1078-0432.CCR-24-4280. Online ahead of print. Clin Cancer Res. 2025. PMID: 40586719
Macrotroponin: A Case Series and Review of the Literature.
Makarious D, Zhou Y, Chung JZY, Ong ATL, Sivagangabalan G, Denniss AR, Thakkar JB, Chow CK. Makarious D, et al. Among authors: chung jzy. Heart Lung Circ. 2025 Jun 26:S1443-9506(25)00182-9. doi: 10.1016/j.hlc.2025.03.006. Online ahead of print. Heart Lung Circ. 2025. PMID: 40579307 Review.
Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma in the East Asian Subgroup of the Phase 3 KEYNOTE-564 Study.
Park SH, Chang YH, Lee JL, Choueiri TK, Kimura G, Chung J, Masumori N, Nishimura K, Kato M, Kato H, Numakura K, Chang CH, Anai S, Tsunemori H, Chen CH, Lin J, Elfiky A, Burgents JE, Kitamura H. Park SH, et al. Among authors: chung j. Cancer Res Treat. 2025 Jun 26. doi: 10.4143/crt.2025.365. Online ahead of print. Cancer Res Treat. 2025. PMID: 40575946 Free article.
12,662 results
You have reached the last available page of results. Please see the User Guide for more information.